Lysergic acid hydroxyethylamide
| Clinical data | |
|---|---|
| Other names | LAH; LSH; Lysergic acid N-(α-hydroxyethyl)amide; Lysergic acid α-hydroxyethylamide; Lysergic acid methyl carbinolamide; N-(1-Hydroxyethyl)lysergamide; N(HOE)-LA; 9,10-Didehydro-N-(1-hydroxyethyl)-6-methylergoline-8-carboxamide |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.020.079 |
| Chemical and physical data | |
| Formula | C18H21N3O2 |
| Molar mass | 311.385 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Lysergic acid hydroxyethylamide (LSH or LAH), also known as lysergic acid N-(α-hydroxyethyl)amide or as lysergic acid methyl carbinolamide, is a lysergamide alkaloid related to the psychedelic drug lysergic acid diethylamide (LSD). It is found in ergot species such as Claviceps paspali and Claviceps purpurea and in the seeds of morning glory species which contain symbiotic fungi such as Periglandula ipomoeae and Periglandula clandestina.
Category:
- Drugs not assigned an ATC code